Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Investigating the clinical factors and co-medications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention.

Turner RM, Fontana V, FitzGerald R, Morris AP, Pirmohamed M.

Br J Clin Pharmacol. 2019 Oct 26. doi: 10.1111/bcp.14133. [Epub ahead of print]

PMID:
31656041
2.

A comparison of arm-based and contrast-based models for network meta-analysis.

White IR, Turner RM, Karahalios A, Salanti G.

Stat Med. 2019 Nov 30;38(27):5197-5213. doi: 10.1002/sim.8360. Epub 2019 Oct 3.

3.

Implications of Cystectomy Travel Distance for Hospital Readmission and Survival.

Hale NE, Macleod LC, Yabes JG, Turner RM 2nd, Fam MM, Gingrich JR, Skolarus TA, Borza T, Sabik LM, Davies BJ, Jacobs BL.

Clin Genitourin Cancer. 2019 Aug 20. pii: S1558-7673(19)30254-X. doi: 10.1016/j.clgc.2019.08.005. [Epub ahead of print]

PMID:
31543443
4.

An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.

Hauser MI, Muscatello DJ, Soh ACY, Dwyer DE, Turner RM.

Vaccine. 2019 Jul 18;37(31):4246-4255. doi: 10.1016/j.vaccine.2019.06.039. Epub 2019 Jun 26. Review.

PMID:
31253447
5.

Patient attitude and acceptance towards episiotomy during pregnancy before and after information provision: a questionnaire.

Alexander JW, Karantanis E, Turner RM, Faasse K, Watt C.

Int Urogynecol J. 2019 Jun 26. doi: 10.1007/s00192-019-04003-x. [Epub ahead of print]

PMID:
31243496
6.

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts.

Just KS, Turner RM, Dolžan V, Cecchin E, Swen JJ, Gurwitz D, Stingl JC.

Clin Pharmacol Ther. 2019 Aug;106(2):313-316. doi: 10.1002/cpt.1471. Epub 2019 Jun 25. No abstract available.

7.

Declining testicular function in the aging stallion: Management options and future therapies.

Turner RM.

Anim Reprod Sci. 2019 Aug;207:171-179. doi: 10.1016/j.anireprosci.2019.06.009. Epub 2019 Jun 8. Review.

PMID:
31227324
8.

Accounting for health literacy and intervention preferences when reducing unhealthy snacking: protocol for an online randomised controlled trial.

Ayre J, Cvejic E, Bonner C, Turner RM, Walter SD, McCaffery KJ.

BMJ Open. 2019 May 28;9(5):e028544. doi: 10.1136/bmjopen-2018-028544.

9.

Bivariate network meta-analysis for surrogate endpoint evaluation.

Bujkiewicz S, Jackson D, Thompson JR, Turner RM, Städler N, Abrams KR, White IR.

Stat Med. 2019 Aug 15;38(18):3322-3341. doi: 10.1002/sim.8187. Epub 2019 May 26.

10.

Rapid mapping of the spatial and temporal intensity of influenza.

Muscatello DJ, Leong RNF, Turner RM, Newall AT.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1307-1312. doi: 10.1007/s10096-019-03554-7. Epub 2019 May 8.

PMID:
31069558
11.

Estimating seasonal variation in Australian pertussis notifications from 1991 to 2016: evidence of spring to summer peaks.

Leong RNF, Wood JG, Turner RM, Newall AT.

Epidemiol Infect. 2019 Jan;147:e155. doi: 10.1017/S0950268818003680.

12.

Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.

Macleod LC, Yabes JG, Yu M, Fam MM, Hale NE, Turner RM 2nd, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL.

Urol Oncol. 2019 Jul;37(7):462-469. doi: 10.1016/j.urolonc.2019.04.006. Epub 2019 Apr 30.

PMID:
31053530
13.

Early-life Chronic Stressors, Rumination, and the Onset of Vulvodynia.

Khandker M, Brady SS, Rydell SA, Turner RM, Schreiner PJ, Harlow BL.

J Sex Med. 2019 Jun;16(6):880-890. doi: 10.1016/j.jsxm.2019.03.010. Epub 2019 Apr 19.

PMID:
31010778
14.

Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer.

Maganty A, Turner RM 2nd, Yabes JG, Davies BJ, Heron DE, Jacobs BL.

Urology. 2019 Jul;129:74-78. doi: 10.1016/j.urology.2019.04.009. Epub 2019 Apr 18.

PMID:
31005656
15.

Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.

Fam MM, Yabes JG, Macleod LC, Bandari J, Turner RM 2nd, Lopa SH, Furlan A, Filson CP, Davies BJ, Jacobs BL.

Urology. 2019 Aug;130:99-105. doi: 10.1016/j.urology.2019.02.037. Epub 2019 Mar 30.

PMID:
30940480
16.

False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.

Nijhuis AAG, Dieng M, Khanna N, Lord SJ, Dalton J, Menzies AM, Turner RM, Allen J, Saw RPM, Nieweg OE, Thompson JF, Morton RL.

Ann Surg Oncol. 2019 Jun;26(6):1860-1868. doi: 10.1245/s10434-019-07311-0. Epub 2019 Mar 25.

PMID:
30911946
17.

Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences.

Walter SD, Turner RM, Macaskill P.

Stat Med. 2019 Jun 15;38(13):2317-2331. doi: 10.1002/sim.8119. Epub 2019 Feb 22.

PMID:
30793786
18.

Palliative care use amongst patients with bladder cancer.

Hugar LA, Lopa SH, Yabes JG, Yu JA, Turner RM 2nd, Fam MM, MacLeod LC, Davies BJ, Smith AB, Jacobs BL.

BJU Int. 2019 Jun;123(6):968-975. doi: 10.1111/bju.14708. Epub 2019 Mar 12.

PMID:
30758125
19.

Maintenance of epigenetic landscape requires CIZ1 and is corrupted in differentiated fibroblasts in long-term culture.

Stewart ER, Turner RML, Newling K, Ridings-Figueroa R, Scott V, Ashton PD, Ainscough JFX, Coverley D.

Nat Commun. 2019 Jan 28;10(1):460. doi: 10.1038/s41467-018-08072-2.

20.

Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for Trypanosomiasis.

Nagendar P, Gillespie JR, Herbst ZM, Ranade RM, Molasky NMR, Faghih O, Turner RM, Gelb MH, Buckner FS.

ACS Med Chem Lett. 2018 Dec 4;10(1):105-110. doi: 10.1021/acsmedchemlett.8b00498. eCollection 2019 Jan 10.

PMID:
30655955
21.

Predictive validity of the CriSTAL tool for short-term mortality in older people presenting at Emergency Departments: a prospective study.

Cardona M, Lewis ET, Kristensen MR, Skjøt-Arkil H, Ekmann AA, Nygaard HH, Jensen JJ, Jensen RO, Pedersen JL, Turner RM, Garden F, Alkhouri H, Asha S, Mackenzie J, Perkins M, Suri S, Holdgate A, Winoto L, Chang DCW, Gallego-Luxan B, McCarthy S, Petersen JA, Jensen BN, Backer Mogensen C, Hillman K, Brabrand M.

Eur Geriatr Med. 2018;9(6):891-901. doi: 10.1007/s41999-018-0123-6. Epub 2018 Oct 31.

22.

Small cell bladder cancer: should we consider prophylactic cranial irradiation?

Morgan TN, Turner RM II, Baptiste J, Lyon TD, Maranchie JK, Hrebinko RL, Davies BJ, Gingrich JR, Jacobs BL.

Int Braz J Urol. 2019 Mar-Apr;45(2):299-305. doi: 10.1590/S1677-5538.IBJU.2018.0242.

23.

Incorporating external evidence on between-trial heterogeneity in network meta-analysis.

Turner RM, Domínguez-Islas CP, Jackson D, Rhodes KM, White IR.

Stat Med. 2019 Apr 15;38(8):1321-1335. doi: 10.1002/sim.8044. Epub 2018 Nov 28.

24.

Prospective Validation of a Checklist to Predict Short-term Death in Older Patients After Emergency Department Admission in Australia and Ireland.

Cardona M, O'Sullivan M, Lewis ET, Turner RM, Garden F, Alkhouri H, Asha S, Mackenzie J, Perkins M, Suri S, Holdgate A, Winoto L, Chang DCW, Gallego-Luxan B, McCarthy S, Hillman K, Breen D.

Acad Emerg Med. 2019 Jun;26(6):610-620. doi: 10.1111/acem.13664. Epub 2018 Dec 14.

25.

Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis.

Hugar LA, Yabes JG, Turner RM 2nd, Fam MM, Appleman LJ, Davies BJ, Jacobs BL.

Urology. 2019 Feb;124:191-197. doi: 10.1016/j.urology.2018.11.001. Epub 2018 Nov 10.

PMID:
30423302
26.

A low literacy targeted talking book about radiation therapy for cancer: development and acceptability.

Smith SK, Cabrera-Aguas M, Shaw J, Shepherd H, Naehrig D, Meiser B, Jackson M, Saade G, Bucci J, Halkett GKB, Turner RM, Milross C, Dhillon HM.

Support Care Cancer. 2019 Jun;27(6):2057-2067. doi: 10.1007/s00520-018-4446-0. Epub 2018 Sep 17.

PMID:
30225574
27.

What information is communicated by radiation therapists to patients during education sessions on the first day of treatment?

Schnitzler L, Smith SK, Shepherd HL, Shaw JM, Dong S, Turner RM, Sørensen K, Dhillon HM.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12911. doi: 10.1111/ecc.12911. Epub 2018 Sep 11.

PMID:
30204270
28.

Who Benefits from Aggressive Rapid Response System Treatments Near the End of Life? A Retrospective Cohort Study.

Cardona M, Turner RM, Chapman A, Alkhouri H, Lewis ET, Jan S, Nicholson M, Parr M, Williamson M, Hillman K.

Jt Comm J Qual Patient Saf. 2018 Sep;44(9):505-513. doi: 10.1016/j.jcjq.2018.04.001. Epub 2018 Jun 27.

PMID:
30166034
29.

Computationally efficient methods for fitting mixed models to electronic health records data.

Rhodes KM, Turner RM, Payne RA, White IR.

Stat Med. 2018 Dec 20;37(29):4557-4570. doi: 10.1002/sim.7944. Epub 2018 Aug 28.

30.

Overlap of Asthma and Chronic Obstructive Pulmonary Disease in Patients in the United States: Analysis of Prevalence, Features, and Subtypes.

Turner RM, DePietro M, Ding B.

JMIR Public Health Surveill. 2018 Aug 20;4(3):e60. doi: 10.2196/publichealth.9930.

31.

Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort.

Turner RM, Fontana V, Bayliss M, Whalley S, Santoyo Castelazo A, Pirmohamed M.

J Pharm Biomed Anal. 2018 Sep 10;159:272-281. doi: 10.1016/j.jpba.2018.06.062. Epub 2018 Jul 3.

32.

Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost.

Turner RM, Ma Q, Lorig K, Greenberg J, DeVries AR.

J Med Internet Res. 2018 Jun 22;20(6):e207. doi: 10.2196/jmir.9225.

33.

Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma.

Lim WY, Turner RM, Morton RL, Jenkins MC, Irwig L, Webster AC, Dieng M, Saw RPM, Guitera P, Low D, Low C, Bell KJL.

BMC Health Serv Res. 2018 Jun 20;18(1):477. doi: 10.1186/s12913-018-3291-7.

34.

Cowper's Gland Syringocele.

Sharbaugh AJ, Yecies TS, Rusilko PJ, Dasyam AK, Turner RM 2nd.

Urology. 2018 Sep;119:e3-e4. doi: 10.1016/j.urology.2018.05.037. Epub 2018 Jun 12.

PMID:
29906481
35.

Effect of multimodal analgesia with paravertebral blocks on biochemical recurrence in men undergoing open radical prostatectomy.

Macleod LC, Turner RM 2nd, Lopa S, Hugar LA, Davies BJ, Ben-David B, Chelly JE, Jacobs BL, Nelson JB.

Urol Oncol. 2018 Aug;36(8):364.e9-364.e14. doi: 10.1016/j.urolonc.2018.05.016. Epub 2018 Jun 7.

PMID:
29887239
36.

Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.

Somes MP, Turner RM, Dwyer LJ, Newall AT.

Vaccine. 2018 May 31;36(23):3199-3207. doi: 10.1016/j.vaccine.2018.04.063. Epub 2018 Apr 30.

PMID:
29716771
37.

An anthropometric approach to characterising neonatal morbidity and body composition, using air displacement plethysmography as a criterion method.

Huvanandana J, Carberry AE, Turner RM, Bek EJ, Raynes-Greenow CH, McEwan AL, Jeffery HE.

PLoS One. 2018 Mar 30;13(3):e0195193. doi: 10.1371/journal.pone.0195193. eCollection 2018.

38.

Efficacy of a tool to predict short-term mortality in older people presenting at emergency departments: Protocol for a multi-centre cohort study.

Cardona M, Lewis ET, Turner RM, Alkhouri H, Asha S, Mackenzie J, Perkins M, Suri S, Holdgate A, Winoto L, Chang CW, Gallego-Luxan B, McCarthy S, Kristensen MR, O'Sullivan M, Skjøt-Arkil H, Ekmann AA, Nygaard HH, Jensen JJ, Jensen RO, Pedersen JL, Breen D, Petersen JA, Jensen BN, Mogensen CB, Hillman K, Brabrand M.

Arch Gerontol Geriatr. 2018 May - Jun;76:169-174. doi: 10.1016/j.archger.2018.02.014. Epub 2018 Mar 6.

PMID:
29524917
39.

Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.

Lim WY, Morton RL, Turner RM, Jenkins MC, Guitera P, Irwig L, Webster AC, Dieng M, Saw RPM, Low D, Low C, Bell KJL.

JAMA Dermatol. 2018 Apr 1;154(4):420-427. doi: 10.1001/jamadermatol.2018.0021.

40.

Population Size Estimation of Gay and Bisexual Men and Other Men Who Have Sex With Men Using Social Media-Based Platforms.

Baral S, Turner RM, Lyons CE, Howell S, Honermann B, Garner A, Hess R III, Diouf D, Ayala G, Sullivan PS, Millett G.

JMIR Public Health Surveill. 2018 Feb 8;4(1):e15. doi: 10.2196/publichealth.9321.

41.

Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases.

Turner RM, Chen YW, Fernandes AW.

Front Pharmacol. 2017 Nov 30;8:883. doi: 10.3389/fphar.2017.00883. eCollection 2017.

42.

Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics.

Rhodes KM, Turner RM, Savović J, Jones HE, Mawdsley D, Higgins JPT.

J Clin Epidemiol. 2018 Mar;95:45-54. doi: 10.1016/j.jclinepi.2017.11.025. Epub 2017 Dec 5.

43.

A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms.

Lopez GH, Turner RM, McGowan EC, Schoeman EM, Scott SA, O'Brien H, Millard GM, Roulis EV, Allen AJ, Liew YW, Flower RL, Hyland CA.

Transfusion. 2018 Mar;58(3):685-691. doi: 10.1111/trf.14439. Epub 2017 Dec 6.

PMID:
29214630
44.

Patient reported outcomes of slow, single arc rotation: Do we need rotating gantries?

Whelan B, Welgampola M, McGarvie L, Makhija K, Turner RM, Holloway L, Feain I, Jackson M, Barton M, Keall P.

J Med Imaging Radiat Oncol. 2017 Nov 15. doi: 10.1111/1754-9485.12688. [Epub ahead of print]

PMID:
29139207
45.

Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study.

Savovic J, Turner RM, Mawdsley D, Jones HE, Beynon R, Higgins JPT, Sterne JAC.

Am J Epidemiol. 2018 May 1;187(5):1113-1122. doi: 10.1093/aje/kwx344.

46.

Participant Satisfaction with a Food Benefit Program with Restrictions and Incentives.

Rydell SA, Turner RM, Lasswell TA, French SA, Oakes JM, Elbel B, Harnack LJ.

J Acad Nutr Diet. 2018 Feb;118(2):294-300. doi: 10.1016/j.jand.2017.08.010. Epub 2017 Oct 27.

47.

Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction.

Nickel B, Dodd RH, Turner RM, Waller J, Marlow L, Zimet G, Ostini R, McCaffery K.

Prev Med Rep. 2017 Oct 10;8:169-176. doi: 10.1016/j.pmedr.2017.10.005. eCollection 2017 Dec.

48.

Label-invariant models for the analysis of meta-epidemiological data.

Rhodes KM, Mawdsley D, Turner RM, Jones HE, Savović J, Higgins JPT.

Stat Med. 2018 Jan 15;37(1):60-70. doi: 10.1002/sim.7491. Epub 2017 Sep 19.

49.

Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden.

Fernandes AW, Wu B, Turner RM.

J Med Econ. 2017 Nov;20(11):1136-1147. doi: 10.1080/13696998.2017.1361960. Epub 2017 Aug 14.

PMID:
28758857
50.

The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.

Bandari J, Ayyash OM, Turner RM 2nd, Jacobs BL, Davies BJ.

Cancer. 2017 Nov 15;123(22):4356-4362. doi: 10.1002/cncr.30914. Epub 2017 Jul 27.

Supplemental Content

Loading ...
Support Center